Molecular residual disease precedes DFS events in patients receiving osimertinib, placebo; most events occur after osimertinib discontinuation or completion.

Nemvaleukin alfa is an investigational engineered fusion protein composed of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain.

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...

The WOLVERINE meta-analysis reinforces the role of MDT in delaying disease progression in patients with oligometastatic ...

Researchers sought to determine whether using HRD sources for HSCT would be effective for pediatric patients with hematologic cancers compared with UCB sources.

Emerging data suggest that SBRT may be comparable with surgery for definitive treatment of stage I NSCLC in certain patients. When is one approach preferred and in whom?

The National Association of Insurance Commissioners (NAIC) is proposing limits on the public disclosure of risk-based capital ...

The following is a summary of “Ability of diastolic arterial pressure to better characterize the severity of septic shock ...